[go: up one dir, main page]

AU2001275651A1 - Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same - Google Patents

Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same

Info

Publication number
AU2001275651A1
AU2001275651A1 AU2001275651A AU7565101A AU2001275651A1 AU 2001275651 A1 AU2001275651 A1 AU 2001275651A1 AU 2001275651 A AU2001275651 A AU 2001275651A AU 7565101 A AU7565101 A AU 7565101A AU 2001275651 A1 AU2001275651 A1 AU 2001275651A1
Authority
AU
Australia
Prior art keywords
curcumin
derivatives
water solubility
improved water
medicaments containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275651A
Inventor
Barbara Bertram
Manfred Hergenhahn
Bernd L. Sorg
Manfred Wiessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of AU2001275651A1 publication Critical patent/AU2001275651A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to curcumin derivatives with improved water solubility compared to curcumin, which are characterized in that the curcumin part is linked to a monosaccharide, oligosaccharide or polysaccharide, and to medicaments containing these derivatives. The curcumin derivatives according to the invention are particularly suitable to prevent and treat cancer, chronic-inflammatory diseases and diseases associated with a retrovirus infection.
AU2001275651A 2000-06-30 2001-06-28 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same Abandoned AU2001275651A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031955A DE10031955A1 (en) 2000-06-30 2000-06-30 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing them
DE10031955 2000-06-30
PCT/DE2001/002337 WO2002002582A1 (en) 2000-06-30 2001-06-28 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same

Publications (1)

Publication Number Publication Date
AU2001275651A1 true AU2001275651A1 (en) 2002-01-14

Family

ID=7647388

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275651A Abandoned AU2001275651A1 (en) 2000-06-30 2001-06-28 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same

Country Status (7)

Country Link
US (1) US20030153512A1 (en)
EP (1) EP1299406B1 (en)
AT (1) ATE307819T1 (en)
AU (1) AU2001275651A1 (en)
CA (1) CA2414605A1 (en)
DE (2) DE10031955A1 (en)
WO (1) WO2002002582A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149113A1 (en) * 2001-10-12 2003-08-07 Caplan Michael J. Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US7718198B2 (en) 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7270835B2 (en) 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7205151B2 (en) 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US7279185B2 (en) 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
NZ532560A (en) * 2001-10-26 2005-02-25 Metaproteomics Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
EP1527127B1 (en) 2002-07-05 2009-02-11 Exxonmobil Chemical Patents Inc. Functionalized elastomer nanocomposite
WO2004031122A1 (en) * 2002-10-01 2004-04-15 Dr. André Rieks - Labor Für Enzymtechnologie Gmbh Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition
DE10245988B4 (en) * 2002-10-01 2005-01-27 Dr. André Rieks, Labor für Enzymtechnologie GmbH New curcumin derivatives for use in cosmetics, pharmaceuticals and nutrition
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
WO2004080396A2 (en) * 2003-03-07 2004-09-23 The University Of Texas Md Anderson Cancer Center Liposomal curcumin for treatment of cancer
JP2005041817A (en) * 2003-07-23 2005-02-17 Japan Science & Technology Agency Curcuminoid glycoside and method for producing the same
US7205011B2 (en) * 2003-11-14 2007-04-17 Board Of Regents, Acting For And On Behalf Of, University Of Arizona Anti-inflammatory activity of a specific turmeric extract
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
ZA200704872B (en) * 2004-11-17 2008-12-31 Mclaurin Joanne Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
US20090170957A1 (en) * 2005-10-13 2009-07-02 Antonio Cruz Scyllo-inositol derivatives and their use in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
US20070197452A1 (en) * 2006-02-17 2007-08-23 Mclaurin Joanne Treatment of amyloid-related diseases
CA2644804A1 (en) * 2006-03-09 2007-09-13 Waratah Pharmaceuticals Inc. A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
WO2007134449A1 (en) * 2006-05-19 2007-11-29 Waratah Pharmaceuticals Inc. Screening methods for amyloid beta modulators
WO2008034244A1 (en) * 2006-09-21 2008-03-27 Waratah Pharmaceuticals Inc. The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases
US20080075671A1 (en) * 2006-09-22 2008-03-27 Di Mauro Thomas M Intranasally administering curcumin to the brain to treat alzheimer's disease
US8487139B2 (en) 2006-10-12 2013-07-16 The Research Foundation Of The City University Of New York Curcumin and tetrahydrocurcumin derivatives
US20100316631A1 (en) * 2006-10-19 2010-12-16 The Uab Research Foundation Water Soluble Curcumin-Based Compounds
CA2670405A1 (en) * 2006-11-24 2008-05-29 Waratah Pharmaceuticals Inc. Combination treatments for alzheimer's disease and related neurodegenerative diseases
JP5124712B2 (en) * 2006-12-28 2013-01-23 マイスターバイオ株式会社 Method for producing polyphenol glycoside
FR2913733B1 (en) 2007-03-14 2009-06-26 Technofan Sa FAN WITH MEANS OF FOLLOW-UP OF WEAR
US20110105626A1 (en) * 2007-04-12 2011-05-05 Mclaurin Joanne Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
US20100331267A1 (en) * 2007-04-12 2010-12-30 Mclaurin Joanne Use of cyclohexanehexol derivatives in the treatment of alpha-synucleinopathies
WO2008124931A1 (en) * 2007-04-12 2008-10-23 Joanne Mclaurin Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
EP2656839A1 (en) * 2007-04-12 2013-10-30 Waratah Pharmaceuticals, Inc. Use of Cyclohexanehexol Derivatives in the Treatment of Ocular Diseases
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
WO2008131059A2 (en) * 2007-04-17 2008-10-30 Codman & Shurtleff, Inc. Intranasally administering curcumin in a bolus of helium gas to treat alzheimer's disease
WO2009023357A2 (en) * 2007-05-25 2009-02-19 University Of Rochester Curcumin derivatives and their use as radioprotectors
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
US9221877B2 (en) 2008-09-19 2015-12-29 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Curcumin conjugates for treating and preventing cancers
CA2740124A1 (en) * 2008-10-09 2010-04-15 Waratah Pharmaceuticals Inc. Use of scyllo-inositols for the treatment of macular degeneration-related disorders
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
KR101157995B1 (en) * 2009-04-28 2012-06-25 차의과학대학교 산학협력단 Novel bis-3-hydroxy-4-methyl-phenyl Derivatives and Methods for Preparing the Same
US9446145B2 (en) 2009-12-02 2016-09-20 Research Foundation Of The City University Of New York Curcumin-antibody conjugates as anti-cancer agents
CA2786255A1 (en) 2009-12-31 2011-07-07 Organomed Corporation Formulations from natural products, turmeric, and aspirin
US9650404B2 (en) 2010-02-26 2017-05-16 Research Foundation Of The City University Of New York Curcumin derivatives
WO2011160093A2 (en) 2010-06-17 2011-12-22 California Institute Of Technology Methods and systems for modulating hormones and related methods, agents and compositions
WO2012004744A2 (en) 2010-07-05 2012-01-12 Polymer Technologies International (Eou) Polymeric composition for ocular devices
EP2714011B1 (en) 2011-06-03 2018-01-31 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
WO2014111831A1 (en) 2013-01-15 2014-07-24 Dave, Jagrat Natavar Toric-diffractive lens
WO2014167425A1 (en) 2013-04-10 2014-10-16 Dave, Jagrat Natavar Phakic lens device with openings and concentric annular zones
CN103396462A (en) * 2013-08-10 2013-11-20 湖州师范学院 Curcumin glucoside and preparation method and application thereof in treating Parkinson disease
JP6224966B2 (en) * 2013-09-12 2017-11-01 ハウス食品グループ本社株式会社 Method for producing monoglycoside of curcuminoid
EP3071190A4 (en) * 2013-11-22 2017-05-31 Signpath Pharma Inc. Intravenous synthetic curcumin (s-curcumin) for the treatment of proliferative disorders
WO2015095576A1 (en) 2013-12-18 2015-06-25 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
EP3151837B1 (en) 2014-06-03 2023-03-15 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies
WO2016034925A1 (en) 2014-09-02 2016-03-10 Dave, Jagrat Natavar Intraocular lens customized for astigmatism or combined astigmatism and presbyopia
ES3014023T3 (en) 2016-04-27 2025-04-16 Signpath Pharma Inc Prevention of drug-induced atrio-ventricular block
US10076552B2 (en) 2016-08-09 2018-09-18 DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
WO2021105137A1 (en) 2019-11-25 2021-06-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Trem-1 inhibitors for the treatment of vaso-occlusions and tissue injuries in patients suffering from sickle cell disease
EP4304626A1 (en) 2021-03-12 2024-01-17 Institut National de la Santé et de la Recherche Médicale (INSERM) Trem-1 inhibitors for the treatment of marfan syndrome
CN113318116B (en) * 2021-06-17 2023-08-25 成都奥睿药业有限公司 The use of curcumin difluoroboron and its derivatives
US20250231196A1 (en) 2021-10-11 2025-07-17 Institut National de la Santé et de la Recherche Médicale Use of trem-1 for predicting and preventing postoperative complications after cardiac surgery with cardiopulmonary by-pass
WO2025196177A1 (en) 2024-03-21 2025-09-25 Institut National de la Santé et de la Recherche Médicale Use of soluble trem-1 as a biomarker for assessing the risk of cardiovascular disease in asymptomatic subjects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999205A (en) * 1989-08-17 1991-03-12 Kalamazoo Holdings, Inc. Curcumin complexed on water-dispersible substrates
IL112205A0 (en) * 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Also Published As

Publication number Publication date
EP1299406A1 (en) 2003-04-09
DE10031955A1 (en) 2002-01-17
ATE307819T1 (en) 2005-11-15
WO2002002582A1 (en) 2002-01-10
CA2414605A1 (en) 2002-12-30
US20030153512A1 (en) 2003-08-14
EP1299406B1 (en) 2005-10-26
DE50107844D1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
AU2001275651A1 (en) Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
AU2119200A (en) Medicament
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
WO2001068092A3 (en) Glycogen phosphorylase inhibitor
DK1412368T3 (en) Sugar derivatives of hydromorphone, dihydromorphine, dihydroisomorphine, their compositions and applications for the treatment or prevention of pain
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
WO2001068034A3 (en) 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
WO2003080582A3 (en) Fredericamycin derivatives
MXPA02007915A (en) Aspirin triggered lipid mediators.
WO2004052280A3 (en) Anti-angiogenic compounds and their use in cancer treatment
AU2002305099A1 (en) Fatty alcohol drug conjugates
WO2002047668A3 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
WO2000066093A3 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2002352531A1 (en) Use of at least one glycoinhibitor substance
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
IN188924B (en)
WO2002002189A3 (en) Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
WO2005009460A3 (en) Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
AU2158601A (en) Antiviral agent for use in treatment of cancer